AI-powered search
Try Polaris, our new AI-powered search!

I tend to prefer Cosentyx and Tremfya since they have the joint indication. Do you think these are coming for the other drugs in these classes?

Featuring Saakshi Khattri , MD |

Assistant Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

| Published April 28, 2022

More from this series

Who is a good candidate for lebrikizumab?

Atopic Dermatitis

Who is a good candidate for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for lebrikizumab?

Atopic Dermatitis

What is the dosing regimen for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the safety profile of lebrikizumab?

Atopic Dermatitis

What is the safety profile of lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

Related Media

Powered by Polaris TM